Financial Personal
Aprea Therapeutics to Present at the Life Sciences Investor Forum on September 19
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com DOYLESTOWN, Pa., Sept. 12, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Read More